REAGENTS CLINICAL MEDICAL LABORATORY

Brand Owner (click to sort) Address Description
AMPLIPREP ROCHE MOLECULAR SYSTEMS, INC. 4300 Hacienda Drive Pleasanton CA 94588 reagents for clinical medical laboratory use;
BIOMARKER BioVentures, Inc. 1435 Kensington Square Court Murfreesboro TN 37130 Reagents for clinical medical laboratory use, namely nucleic acid fragment sizing standards for the determination of nucleic acid fragment lengths; kits composed primarily of the reagents;
COMMON-SENSE Antivirals Inc. One S.W. Columbia, Suite 1105 Portland OR 97258 reagents for clinical medical laboratory and diagnostic use, namely, polymers for binding major groove sites in duplexes containing one or two strands of nucleic acids, and for therapeutic use in the treatment of cancer, inflammation, and infectious disease;reagents for scientific and medical research use, namely, polymers for binding major groove sites in duplexes containing one or two strands of nucleic acids;
DAKO ENVISION DAKO A/S PRODUKTIONSVEJ 42 DK-2600 GLOSTRUP Denmark reagents for clinical medical laboratory use;
DAKO EPOS DAKO A/S PRODUKTIONSVEJ 42 DK-2600 GLOSTRUP Denmark reagents for clinical medical laboratory use in the detection of antigens;
DR-70 AMDL, Inc. 14272 Franklin Avenue Tustin CA 926807017 Reagents for clinical medical laboratory use;
DR-70 AMDL DIAGNOSTICS INC 2492 WALNUT AVE, SUITE 100 TUSTIN CA 92780 Reagents for clinical medical laboratory use sold as a component of a diagnostic kit for disease testing;
DUKE SCIENTIFIC CORPORATION Duke Scientific Corporation 2463 Faber Place Palo Alto CA 94303 reagents for clinical medical laboratory use;reagents for scientific research;SCIENTIFIC CORPORATION;
GA PROBE KIT Clingenix, Inc. 871 Industrial Road, Suite J San Carlos CA 94070 Reagents for clinical medical laboratory use; kits comprised of clinical medical reagents, cells for clinical medical use, tubes, vials, plates with multiple wells, bacteria, cells, cell extracts, buffer solutions, emulsions, plasmid DNA, human and bacterial genomic DNA, single stranded DNA, double stranded DNA, transfer RNA, messenger RNA, proteins, fluorescent dyes, clorometric dyes, antibodies, antigens, chemiluminescence dyes and tags, radioactive tags, bottles for solutions, and suspensions and buffers, all for use in investigating genetic markers and gene expressions for clinical medical laboratory use;PROBE KIT;
MINIQUANT TCOAG IRELAND LIMITED 70 Sir John Rogerson's Quay Dublin 2 Ireland REAGENTS FOR CLINICAL MEDICAL LABORATORY USE;MINI QUANT;
ONCOSTAT THERIAK S.A. 4, ROUTE DE BEAUMONT FRIBOURG Switzerland reagents for clinical medical laboratory use; autologous tumor cell vaccines to be used in active specific immunotherapy; human cells treated with chemicals or biologicals, and biologicals used for the medical treatment of human cancer cells; and pharmaceuticals and medicines for the detection and treatment of cancer affectations;onco-stat;diagnostic chemicals specifically used for the determination of malignancy in humans and animals for scientific or research use; human cells treated with chemicals or biologicals, and biologicals used for the preparation of autologous tumor cell vaccines;
PRIMUS RESOLUTION PRIMUS CORPORATION 4231 E. 75th Terrace Kansas City MO 64132 Reagents for clinical medical laboratory use (Diagnostic);
PROTEIN BOUND GLUCOSE National Screening Institute 904 Via Lido Nord Newport Beach CA 92663 reagents for clinical medical laboratory use and clinical medical laboratory kits containing such reagents;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. A method and apparatus are provided for adjusting a dynamic range of a digital medical image for a medical imaging system. The digital medical image contains a clinical region and a non-clinical region. The method and apparatus identify the non-clinical region of the digital medical image and mask the non-clinical region therefrom to form a clinical image. The clinical image is then used to calculate a desired dynamic range for the medical imaging system. The dynamic range of the medical imaging system is adjusted accordingly. According to one embodiment, the non-clinical region is identified by dividing the digital medical image into bands of a predetermined width, generating profiles for each band and differentiating the profiles to obtain a differentiated profile of each band of a digital medical image. The differentiated profile is than analyzed to identify peaks that exceed predetermined thresholds, wherein the regions of the differentiated profile proximate the peaks exceeding the threshold correspond to non-clinical regions. Once the non-clinical regions are identified, they are masked or removed. Next, a desired image characteristic, such as maximum and minimum gray scale values, are determined for the clinical region and a desired dynamic range for the image is obtained based on the image characteristics of the clinical region. In an alternative embodiment, a histogram is used to identify the non-clinical regions which are subsequently masked from the digital medical image.